Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma.

Koay EJ, Lee Y, Cristini V, Lowengrub JS, Kang Y, Lucas FAS, Hobbs BP, Ye R, Elganainy D, Almahariq M, Amer AM, Chatterjee D, Yan H, Park PC, Rios Perez MV, Li D, Garg N, Reiss KA, Yu S, Chauhan A, Zaid M, Nikzad N, Wolff RA, Javle M, Varadhachary GR, Shroff RT, Das P, Lee JE, Ferrari M, Maitra A, Taniguchi CM, Kim MP, Crane CH, Katz MH, Wang H, Bhosale P, Tamm EP, Fleming JB.

Clin Cancer Res. 2018 Aug 6. doi: 10.1158/1078-0432.CCR-17-3668. [Epub ahead of print]

PMID:
30082477
2.

Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation.

Fang P, Shiraishi Y, Verma V, Jiang W, Song J, Hobbs BP, Lin SH.

Int J Part Ther. 2018 Winter;4(3):23-32. doi: 10.14338/IJPT-17-00033.1.

3.

Estimating mean local posterior predictive benefit for biomarker-guided treatment strategies.

Huang M, Hobbs BP.

Stat Methods Med Res. 2018 Jan 1:962280218788099. doi: 10.1177/0962280218788099. [Epub ahead of print]

PMID:
30037304
4.

Bayesian basket trial design with exchangeability monitoring.

Hobbs BP, Landin R.

Stat Med. 2018 Jul 8. doi: 10.1002/sim.7893. [Epub ahead of print]

PMID:
29984488
5.

Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis.

Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier ND, Lee JE, Prieto VG, Hobbs BP.

AJR Am J Roentgenol. 2018 Aug;211(2):W109-W115. doi: 10.2214/AJR.17.19103. Epub 2018 Jun 27.

6.

Multimodal Imaging of Pathologic Response to Chemoradiation in Esophageal Cancer.

Fang P, Musall BC, Son JB, Moreno AC, Hobbs BP, Carter BW, Fellman BM, Mawlawi O, Ma J, Lin SH.

Int J Radiat Oncol Biol Phys. 2018 Mar 2. pii: S0360-3016(18)30328-6. doi: 10.1016/j.ijrobp.2018.02.029. [Epub ahead of print]

PMID:
29685377
7.

Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models.

Ng CS, Wei W, Altinmakas E, Li X, Ghosh P, Perrier NA, Grubbs E, Prieto VG, Lee JE, Hobbs BP.

AJR Am J Roentgenol. 2018 Apr;210(4):W156-W163. doi: 10.2214/AJR.17.18428. Epub 2018 Feb 7.

PMID:
29412015
8.

Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance.

Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier NA, Prieto VG, Lee JE, Hobbs BP.

Acad Radiol. 2018 Jul;25(7):861-868. doi: 10.1016/j.acra.2017.12.005. Epub 2018 Feb 3.

PMID:
29398440
9.

A multi-source adaptive platform design for testing sequential combinatorial therapeutic strategies.

Kaizer AM, Hobbs BP, Koopmeiners JS.

Biometrics. 2018 Jan 22. doi: 10.1111/biom.12841. [Epub ahead of print]

PMID:
29359450
10.

Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.

Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SH.

Radiother Oncol. 2018 Jul;128(1):154-160. doi: 10.1016/j.radonc.2017.11.028. Epub 2017 Dec 14.

11.

Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.

Yu W, Tang C, Hobbs BP, Li X, Koay EJ, Wistuba II, Sepesi B, Behrens C, Rodriguez Canales J, Parra Cuentas ER, Erasmus JJ, Court LE, Chang JY.

Int J Radiat Oncol Biol Phys. 2017 Nov 15. pii: S0360-3016(17)34061-0. doi: 10.1016/j.ijrobp.2017.10.046. [Epub ahead of print]

PMID:
29246722
12.

Tree-based Methods for Characterizing Tumor Density Heterogeneity.

Shoemaker K, Hobbs BP, Bharath K, Ng CS, Baladandayuthapani V.

Pac Symp Biocomput. 2018;23:216-227.

13.

Quantification of the Effect of Shuttling on Computed Tomography Perfusion Parameters by Investigation of Aortic Inputs on Different Table Positions From Shuttle-Mode Scans of Lung and Liver Tumors.

Ghosh P, Chandler AG, Hobbs BP, Sun J, Rong J, Hong D, Subbiah V, Janku F, Naing A, Hwu WJ, Ng CS.

J Comput Assist Tomogr. 2018 May/Jun;42(3):357-364. doi: 10.1097/RCT.0000000000000686.

PMID:
29189398
14.

Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus.

Xu C, Xi M, Komaki R, Balter PA, Huang M, Hobbs BP, Wang L, Lin SH.

Adv Radiat Oncol. 2017 Mar 27;2(3):325-332. doi: 10.1016/j.adro.2017.03.006. eCollection 2017 Jul-Sep.

15.

Bayesian hierarchical modeling based on multisource exchangeability.

Kaizer AM, Koopmeiners JS, Hobbs BP.

Biostatistics. 2018 Apr 1;19(2):169-184. doi: 10.1093/biostatistics/kxx031.

PMID:
29036300
16.

RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer.

Wang Y, Gudikote J, Giri U, Yan J, Deng W, Ye R, Jiang W, Li N, Hobbs BP, Wang J, Swisher SG, Fujimoto J, Wistuba II, Komaki R, Heymach JV, Lin SH.

Clin Cancer Res. 2018 Jan 15;24(2):341-350. doi: 10.1158/1078-0432.CCR-17-1455. Epub 2017 Oct 13.

PMID:
29030353
17.

Definitive Chemoradiation Therapy for Esophageal Cancer in the Elderly: Clinical Outcomes for Patients Exceeding 80 Years Old.

Xu C, Xi M, Moreno A, Shiraishi Y, Hobbs BP, Huang M, Komaki R, Lin SH.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):811-819. doi: 10.1016/j.ijrobp.2017.02.097. Epub 2017 Mar 1.

PMID:
28602412
18.

A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.

Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A Jr, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT.

Ann Surg. 2018 May;267(5):946-951. doi: 10.1097/SLA.0000000000002313.

PMID:
28549010
19.

Combining Non-randomized and Randomized Data in Clinical Trials Using Commensurate Priors.

Zhao H, Hobbs BP, Ma H, Jiang Q, Carlin BP.

Health Serv Outcomes Res Methodol. 2016 Sep;16(3):154-171. doi: 10.1007/s10742-016-0155-7. Epub 2016 Aug 6.

20.

Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis.

Ehrmann S, Quartin A, Hobbs BP, Robert-Edan V, Cely C, Bell C, Lyons G, Pham T, Schein R, Geng Y, Lakhal K, Ng CS.

Intensive Care Med. 2017 Jun;43(6):785-794. doi: 10.1007/s00134-017-4700-9. Epub 2017 Feb 14. Review.

PMID:
28197679
21.

INTEGRATIVE BAYESIAN ANALYSIS OF NEUROIMAGING-GENETIC DATA THROUGH HIERARCHICAL DIMENSION REDUCTION.

Azadeh S, Hobbs BP, Ma L, Nielsen DA, Moeller FG, Baladandayuthapani V.

Proc IEEE Int Symp Biomed Imaging. 2016 Apr;2016:824-828. Epub 2016 Jun 16.

22.

Integrating genomic signatures for treatment selection with Bayesian predictive failure time models.

Ma J, Hobbs BP, Stingo FC.

Stat Methods Med Res. 2018 Jul;27(7):2093-2113. doi: 10.1177/0962280216675373. Epub 2016 Nov 1.

23.

Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard.

Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS.

Abdom Radiol (NY). 2017 Feb;42(2):577-584. doi: 10.1007/s00261-016-0915-4.

PMID:
27665482
24.

Detecting and accounting for violations of the constancy assumption in non-inferiority clinical trials.

Koopmeiners JS, Hobbs BP.

Stat Methods Med Res. 2018 May;27(5):1547-1558. doi: 10.1177/0962280216665418. Epub 2016 Sep 1.

25.

Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma.

Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA.

Laryngoscope. 2017 Apr;127(4):842-848. doi: 10.1002/lary.26153. Epub 2016 Jul 21.

26.

Hypocalcemia in trauma patients receiving massive transfusion.

Giancarelli A, Birrer KL, Alban RF, Hobbs BP, Liu-DeRyke X.

J Surg Res. 2016 May 1;202(1):182-7. doi: 10.1016/j.jss.2015.12.036. Epub 2015 Dec 30.

PMID:
27083965
27.

Flexible Bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effects.

Murray TA, Hobbs BP, Sargent DJ, Carlin BP.

Bayesian Anal. 2016 Jun;11(2):381-402. Epub 2015 May 14.

28.

Bayesian Group Sequential Clinical Trial Design using Total Toxicity Burden and Progression-Free Survival.

Hobbs BP, Thall PF, Lin SH.

J R Stat Soc Ser C Appl Stat. 2016 Feb;65(2):273-297. Epub 2015 Oct 26.

29.

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.

Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM.

J Clin Oncol. 2016 Apr 1;34(10):1072-8. doi: 10.1200/JCO.2015.64.0094. Epub 2016 Jan 25.

30.

Controlled multi-arm platform design using predictive probability.

Hobbs BP, Chen N, Lee JJ.

Stat Methods Med Res. 2018 Jan;27(1):65-78. doi: 10.1177/0962280215620696. Epub 2016 Jan 12.

31.

Assessing the role of ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.

Etchebehere EC, Hobbs BP, Milton DR, Malawi O, Patel S, Benjamin RS, Macapinlac HA.

Eur J Nucl Med Mol Imaging. 2016 May;43(5):860-70. doi: 10.1007/s00259-015-3242-z. Epub 2015 Dec 3. Review.

32.

MRI may be used as a prognostic indicator in patients with extra-abdominal desmoid tumours.

Kamali F, Wang WL, Guadagnolo BA, Fox PS, Lewis VO, Lazar AJ, Conley AP, Ravi V, Toliyat M, Ladha HS, Hobbs BP, Amini B.

Br J Radiol. 2016;89(1058):20150308. doi: 10.1259/bjr.20150308. Epub 2015 Nov 18.

33.

Bayesian predictive modeling for genomic based personalized treatment selection.

Ma J, Stingo FC, Hobbs BP.

Biometrics. 2016 Jun;72(2):575-83. doi: 10.1111/biom.12448. Epub 2015 Nov 17.

34.

COMBINING NONEXCHANGEABLE FUNCTIONAL OR SURVIVAL DATA SOURCES IN ONCOLOGY USING GENERALIZED MIXTURE COMMENSURATE PRIORS.

Murray TA, Hobbs BP, Carlin BP.

Ann Appl Stat. 2015 Sep;9(3):1549-1570. Epub 2015 Nov 2.

35.

CT Perfusion Characteristics Identify Metastatic Sites in Liver.

Wang Y, Hobbs BP, Ng CS.

Biomed Res Int. 2015;2015:120749. doi: 10.1155/2015/120749. Epub 2015 Oct 5.

36.

On nonparametric hazard estimation.

Hobbs BP.

J Biom Biostat. 2015;6. pii: 232. Epub 2015 Jun 18.

37.

Integrative Bayesian analysis of neuroimaging-genetic data with application to cocaine dependence.

Azadeh S, Hobbs BP, Ma L, Nielsen DA, Gerard Moeller F, Baladandayuthapani V.

Neuroimage. 2016 Jan 15;125:813-824. doi: 10.1016/j.neuroimage.2015.10.033. Epub 2015 Oct 17.

38.

Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study.

Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD.

NMR Biomed. 2015 Dec;28(12):1645-54. doi: 10.1002/nbm.3412. Epub 2015 Oct 9.

39.

Statistical Methods for Establishing Personalized Treatment Rules in Oncology.

Ma J, Hobbs BP, Stingo FC.

Biomed Res Int. 2015;2015:670691. doi: 10.1155/2015/670691. Epub 2015 Sep 13. Review.

40.

Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.

Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT.

Ann Surg Oncol. 2016 Feb;23(2):482-9. doi: 10.1245/s10434-015-4876-6. Epub 2015 Sep 28.

41.

From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Raghav KP, Mahajan S, Yao JC, Hobbs BP, Berry DA, Pentz RD, Tam A, Hong WK, Ellis LM, Abbruzzese J, Overman MJ.

J Clin Oncol. 2015 Nov 1;33(31):3583-90. doi: 10.1200/JCO.2015.62.4148. Epub 2015 Aug 24. Review.

42.

Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT.

Rohren EM, Etchebehere EC, Araujo JC, Hobbs BP, Swanston NM, Everding M, Moody T, Macapinlac HA.

J Nucl Med. 2015 Oct;56(10):1507-12. doi: 10.2967/jnumed.115.156026. Epub 2015 Jul 1.

43.

Tumor T1 Relaxation Time for Assessing Response to Bevacizumab Anti-Angiogenic Therapy in a Mouse Ovarian Cancer Model.

Ravoori MK, Nishimura M, Singh SP, Lu C, Han L, Hobbs BP, Pradeep S, Choi HJ, Bankson JA, Sood AK, Kundra V.

PLoS One. 2015 Jun 22;10(6):e0131095. doi: 10.1371/journal.pone.0131095. eCollection 2015.

44.

Inferring Stable Acquisition Durations for Applications of Perfusion Imaging in Oncology.

Hobbs BP, Ng CS.

Cancer Inform. 2015 May 25;14(Suppl 2):193-9. doi: 10.4137/CIN.S17280. eCollection 2015.

45.

Predictive classification of correlated targets with application to detection of metastatic cancer using functional CT imaging.

Wang Y, Hobbs BP, Hu J, Ng CS, Do KA.

Biometrics. 2015 Sep;71(3):792-802. doi: 10.1111/biom.12304. Epub 2015 Apr 7.

46.

Dynamic contrast-enhanced MRI for the detection of prostate cancer: meta-analysis.

Tan CH, Hobbs BP, Wei W, Kundra V.

AJR Am J Roentgenol. 2015 Apr;204(4):W439-48. doi: 10.2214/AJR.14.13373.

47.

Effect on perfusion values of sampling interval of computed tomographic perfusion acquisitions in neuroendocrine liver metastases and normal liver.

Ng CS, Hobbs BP, Wei W, Anderson EF, Herron DH, Yao JC, Chandler AG.

J Comput Assist Tomogr. 2015 May-Jun;39(3):373-82. doi: 10.1097/RCT.0000000000000212.

48.

A Bayesian Nonparametric Approach for Functional Data Classification with Application to Hepatic Tissue Characterization.

Fronczyk KM, Guindani M, Hobbs BP, Ng CS, Vannucci M.

Cancer Inform. 2016 May 29;14(Suppl 5):151-62. doi: 10.4137/CIN.S31933. eCollection 2015.

49.

Differentiation of Benign Fluid Collections from Soft-Tissue Sarcomas on FDG-PET/CT.

Amini B, Madewell JE, Chuang HH, Haygood TM, Hobbs BP, Fox PS, Bassett RL, Costelloe CM.

J Cancer. 2014 Mar 22;5(5):328-35. doi: 10.7150/jca.8310. eCollection 2014.

50.

Effect of pre-enhancement set point on computed tomographic perfusion values in normal liver and metastases to the liver from neuroendocrine tumors.

Ng CS, Chandler AG, Yao JC, Herron DH, Anderson EF, Charnsangavej C, Hobbs BP.

J Comput Assist Tomogr. 2014 Jul-Aug;38(4):526-34. doi: 10.1097/RCT.0000000000000053.

Supplemental Content

Loading ...
Support Center